Innovator Capital Management, LLC (Innovator), pioneer and provider of the first and largest lineup of Defined Outcome ETFs™, today announced the launch of the Innovator Equity Premium Income - Daily ...

Barre Syndrome (GBS) - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering. This comprehensive analysis of the Guillain-Barré Syndrome (GBS) pipeline is a testament to ...

As Guillain-Barre Syndrome (GBS) cases rise, so does the social media buzz. Many theories are being floated on the dos and don’ts, which people are likely to believe. One such is avoiding meat.

GBS outbreak: The death count from the recent Guillain-Barre Syndrome (GBS) outbreak has risen to 11 after two more patients died in Pune hospitals during treatment, officials said on Wednesday ...

GBS typically presented as slowly progressive weakness in the legs or arms. (Image Credits: Pixabay) GBS Outbreak: After a 59-year-old resident of Khadakwasla died due to Guillain-Barre Syndrome ...

The man was admitted to Nair Hospital on January 26 after weakness and symptoms of GBS were noticed. According to information put out by the BMC’s health department, he was kept in the Intensive ...

Of the 8 deaths reported, 4 deaths have been confirmed as GBS Mumbai:Some 181 patients have been infected with Guillain-Barre Syndrome (GBS) in the state so far, according to the Integrated ...

Guillain-Barre Syndrome (GBS) is a rare autoimmune disorder in which the body's immune system mistakenly attacks the peripheral nerves, which are responsible for transmitting signals between the ...

Kochi: The first GBS death was on Tuesday reported in Kerala after a 58-year-old died of Guillain-Barre Syndrome in Kochi. The patient was undergoing treatment in Kottayam Medical College.

Guillain-Barré Syndrome (GBS) is an uncommon but deadly disorder in which the immune system attacks the nerves, causing muscular weakness and sometimes paralysis. Recently, the National Institute ...

Robust, Consistent Phase 3 Data and Real-World Evidence Outcomes Support ANX005 as Potential First Targeted Therapy for GBS; Pre-BLA Meeting ...